Ontario Consortium for Regeneration Inducing Therapeutics (OCRiT)
The Ontario Consortium for Regeneration Inducing Therapeutics is an innovation-driven program, lead by McMaster University and the Stem Cell and Cancer Research Institute (SCC-RI). OCRiT focuses on employing unique properties of stem cells to the discovery and development of advanced medical treatments.
Strategically positioned in the Province of Ontario the OCRiT program brings together a multi-disciplinary team of internationally renowned scientific leaders in the fields of novel natural products, medicinal chemistry, stem cell biology and bioinformatics.
In its early years, OCRiT focus lies on the creation of novel chemical matter and the application of stem cells to high throughput platforms. These efforts will constitute the basis for the identification of unique stem cell properties, which are paramount for the development of revolutionary drug discovery approaches.
The long-term objective of the program is to identify and develop chemical based therapeutics that will serve as tools for replacement therapy and as novel drugs for the treatment of degenerative disease by inducing in vivo activation of endogenous stem cells residing in damaged tissue.